Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Clinical data disclosed on gabapentin enacarbil in restless legs syndrome

April 15, 2010

Pfizer presents new 5-HT2C receptor agonists with antiobesity potential

April 15, 2010

Clinical data disclosed on lamotrigine in secondary progressive multiple sclerosis

April 14, 2010

Bazedoxifene shows potential as endometriosis therapy in preclinical study

April 14, 2010

Almirall presents new DHODH inhibitors suitable for clinical development

April 14, 2010

Preliminary data disclosed from long-term safety/efficacy phase III trial of LibiGel in HSDD

April 14, 2010

Vantia discloses dysmenorrhea candidate VA-111913 at ACS meeting

April 13, 2010

Gaucher's disease patients achieve key therapeutic goals with velaglucerase alfa

April 13, 2010

Johnson & Johnson reports new HIF prolyl hydroxylase inhibitors

April 13, 2010

Novartis optimizes lysophospholipid receptor S1P1 agonists

April 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...